Characteristics of older adults who were early adopters of medical cannabis in the Florida Medical Marijuana Use Registry JD Brown, B Costales, S van Boemmel-Wegmann, AJ Goodin, R Segal, ... Journal of clinical medicine 9 (4), 1166, 2020 | 48 | 2020 |
A mapping literature review of medical cannabis clinical outcomes and quality of evidence in approved conditions in the USA from 2016 to 2019 S Jugl, A Okpeku, B Costales, EJ Morris, G Alipour-Haris, ... Medical Cannabis and Cannabinoids 4 (1), 21-42, 2021 | 33 | 2021 |
Outpatient off-label gabapentin use for psychiatric indications among US adults, 2011–2016 B Costales, AJ Goodin Psychiatric Services 72 (11), 1246-1253, 2021 | 9 | 2021 |
Practice patterns and training needs among physicians certifying patients for medical marijuana in Florida R Sajdeya, A Shavers, J Jean-Jacques, B Costales, S Jugl, C Crump, ... Journal of primary care & community health 12, 21501327211042790, 2021 | 7 | 2021 |
Clinical conditions and prescription drug utilization among early medical marijuana registrants in Florida B Costales, S van Boemmel-Wegmann, A Winterstein, R Segal Journal of psychoactive Drugs 53 (3), 185-194, 2021 | 6 | 2021 |
A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019. Medical cannabis and cannabinoids … S Jugl, A Okpeku, B Costales, EJ Morris, G Alipour-Haris, ... | 5 | 2021 |
Treatment initiation and utilization patterns of pharmacotherapies for early-onset idiopathic restless legs syndrome B Costales, SM Vouri, JD Brown, B Setlow, AJ Goodin Sleep medicine 96, 70-78, 2022 | 3 | 2022 |
Pdg46 outpatient off-label gabapentin utilization from 2011 to 2015 among United States adults B Costales, JD Brown, AJ Goodin Value in Health 23, S137, 2020 | 1 | 2020 |
On-and Off-Label Atypical Antipsychotic Prescription Trends Across a Nine-Year Period Among Adolescents Pre-to Post-COVID-19 B Costales, NE Slama, RB Penfold, JR Nugent, SR Spalding, SA Sterling, ... Academic Pediatrics, 2024 | | 2024 |
Glucagon-like peptide-1 (GLP-1) analogues as a novel pharmacotherapeutic approach for alcohol use disorder (AUD) V Palzes, S Sterling, A Kline-Simon, B Costales, L Leggio, M Farokhnia OSF, 2024 | | 2024 |
Cannabis effects on driving performance: clinical considerations B Costales, SL Babalonis, JD Brown, AJ Goodin Medical Cannabis and Cannabinoids 6 (1), 8-14, 2023 | | 2023 |
Incident mental health episodes after initiation of gabapentinoids vs. dopamine agonists for early-onset idiopathic restless legs syndrome B Costales, SM Vouri, JD Brown, B Setlow, AJ Goodin Psychiatry Research 328, 115479, 2023 | | 2023 |
HSD106 Trends in Second Generation Antipsychotic Prescribing for Adolescents from 2013-2021 B Costales, N Slama, RB Penfold, SR Spalding, SA Sterling, E Iturralde Value in Health 26 (6), S257, 2023 | | 2023 |
CO133 Initiation of Pharmacotherapies for Newly Diagnosed Early-Onset Idiopathic Restless Legs Syndrome from 2012-2019 B Costales, SM Vouri, JD Brown, B Setlow, AJ Goodin Value in Health 25 (7), S329, 2022 | | 2022 |
Utilization and Safety of Pharmacological Treatments for Early-Onset Idiopathic Restless Legs Syndrome B Costales University of Florida, 2022 | | 2022 |
A pharmacovigilance analysis of restless legs syndrome treatments and suicidality B Costales, RA Matthews, JD Brown, AJ Goodin PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 30, 124-125, 2021 | | 2021 |
Evaluation of a potential gabapentinoid-somnolence-stimulant prescribing cascade among adults: A prescription sequence symmetry analysis EJ Morris, B Costales, X Jiang, A Goodin, SM Vouri PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 483-484, 2020 | | 2020 |
Off-label gabapentin utilization for psychiatric indications using the food and drug administration adverse event reporting system database from 1993-2019 B Costales, JD Brown, C Henriksen, AJ Goodin PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 271-271, 2020 | | 2020 |
A descriptive analysis of Florida medical marijuana registry patients from 2016-2017 B Costales, S van Boemmel-Wegmann, R Segal PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 28, 268-268, 2019 | | 2019 |
Changes in Prevalence of High-Risk Opioid Use Quality Measures in Arizona, 2011-2018 A Goodin, J Huang, H Park, J Hincapie-Castillo, J Brown, B Costales, ... 2020 Virtual Annual Research Meeting, 0 | | |